SRDAN VERSTOVSEK to Isonicotinic Acids
This is a "connection" page, showing publications SRDAN VERSTOVSEK has written about Isonicotinic Acids.
Connection Strength
0.569
-
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis. Haematologica. 2017 02; 102(2):327-335.
Score: 0.569
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.